IBDEI0JU ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,8745,0)
 ;;=90472^^68^592^2^^^^1
 ;;^UTILITY(U,$J,358.3,8745,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,8745,1,2,0)
 ;;=2^90472
 ;;^UTILITY(U,$J,358.3,8745,1,3,0)
 ;;=3^IMMUNIZATION ADMIN,EA ADDL VACCINE
 ;;^UTILITY(U,$J,358.3,8746,0)
 ;;=90999^^68^593^1^^^^1
 ;;^UTILITY(U,$J,358.3,8746,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,8746,1,2,0)
 ;;=2^90999
 ;;^UTILITY(U,$J,358.3,8746,1,3,0)
 ;;=3^Daily Dialysis Treatment
 ;;^UTILITY(U,$J,358.3,8747,0)
 ;;=90935^^68^594^1^^^^1
 ;;^UTILITY(U,$J,358.3,8747,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,8747,1,2,0)
 ;;=2^90935
 ;;^UTILITY(U,$J,358.3,8747,1,3,0)
 ;;=3^HEMODIALYSIS SINGLE EVAL
 ;;^UTILITY(U,$J,358.3,8748,0)
 ;;=90937^^68^594^2^^^^1
 ;;^UTILITY(U,$J,358.3,8748,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,8748,1,2,0)
 ;;=2^90937
 ;;^UTILITY(U,$J,358.3,8748,1,3,0)
 ;;=3^HEMODIALYSIS REPEATED EVAL
 ;;^UTILITY(U,$J,358.3,8749,0)
 ;;=90945^^68^594^3^^^^1
 ;;^UTILITY(U,$J,358.3,8749,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,8749,1,2,0)
 ;;=2^90945
 ;;^UTILITY(U,$J,358.3,8749,1,3,0)
 ;;=3^PERITONEAL DIALYSIS,SINGLE EVAL
 ;;^UTILITY(U,$J,358.3,8750,0)
 ;;=90947^^68^594^4^^^^1
 ;;^UTILITY(U,$J,358.3,8750,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,8750,1,2,0)
 ;;=2^90947
 ;;^UTILITY(U,$J,358.3,8750,1,3,0)
 ;;=3^PERITONEAL DIALYSIS,REPEATED EVAL
 ;;^UTILITY(U,$J,358.3,8751,0)
 ;;=90945^^68^595^1^^^^1
 ;;^UTILITY(U,$J,358.3,8751,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,8751,1,2,0)
 ;;=2^90945
 ;;^UTILITY(U,$J,358.3,8751,1,3,0)
 ;;=3^MISC DIALYSIS & PROC;SINGLE VISIT
 ;;^UTILITY(U,$J,358.3,8752,0)
 ;;=90947^^68^595^2^^^^1
 ;;^UTILITY(U,$J,358.3,8752,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,8752,1,2,0)
 ;;=2^90947
 ;;^UTILITY(U,$J,358.3,8752,1,3,0)
 ;;=3^MISC DIALYSIS & PROC;MULT VISITS
 ;;^UTILITY(U,$J,358.3,8753,0)
 ;;=99366^^68^596^1^^^^1
 ;;^UTILITY(U,$J,358.3,8753,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,8753,1,2,0)
 ;;=2^99366
 ;;^UTILITY(U,$J,358.3,8753,1,3,0)
 ;;=3^MED TEAM CONF,FTF,> 29 MIN
 ;;^UTILITY(U,$J,358.3,8754,0)
 ;;=99367^^68^596^2^^^^1
 ;;^UTILITY(U,$J,358.3,8754,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,8754,1,2,0)
 ;;=2^99367
 ;;^UTILITY(U,$J,358.3,8754,1,3,0)
 ;;=3^MED TEAM CONF W/O FTF;PHYSICIAN
 ;;^UTILITY(U,$J,358.3,8755,0)
 ;;=99368^^68^596^3^^^^1
 ;;^UTILITY(U,$J,358.3,8755,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,8755,1,2,0)
 ;;=2^99368
 ;;^UTILITY(U,$J,358.3,8755,1,3,0)
 ;;=3^MED TEAM CONF W/O FTF PT/FAM;NONPHY
 ;;^UTILITY(U,$J,358.3,8756,0)
 ;;=Z49.31^^69^597^1
 ;;^UTILITY(U,$J,358.3,8756,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8756,1,3,0)
 ;;=3^Adequacy Testing for Hemodialysis
 ;;^UTILITY(U,$J,358.3,8756,1,4,0)
 ;;=4^Z49.31
 ;;^UTILITY(U,$J,358.3,8756,2)
 ;;=^5063058
 ;;^UTILITY(U,$J,358.3,8757,0)
 ;;=N18.6^^69^597^3
 ;;^UTILITY(U,$J,358.3,8757,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8757,1,3,0)
 ;;=3^ESRD
 ;;^UTILITY(U,$J,358.3,8757,1,4,0)
 ;;=4^N18.6
 ;;^UTILITY(U,$J,358.3,8757,2)
 ;;=^303986
 ;;^UTILITY(U,$J,358.3,8758,0)
 ;;=Z99.2^^69^597^2
 ;;^UTILITY(U,$J,358.3,8758,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8758,1,3,0)
 ;;=3^Dependence on Renal Dialysis
 ;;^UTILITY(U,$J,358.3,8758,1,4,0)
 ;;=4^Z99.2
 ;;^UTILITY(U,$J,358.3,8758,2)
 ;;=^5063758
 ;;^UTILITY(U,$J,358.3,8759,0)
 ;;=Z91.15^^69^597^4
 ;;^UTILITY(U,$J,358.3,8759,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8759,1,3,0)
 ;;=3^Patient's Noncompliance w/ Renal Dialysis
